Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
about
EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcriptionHuman cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expressionEpstein-Barr virus and virus human protein interaction mapsKeeping it quiet: chromatin control of gammaherpesvirus latencyThe potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1Proteomic analysis of detergent resistant membrane domains during early interaction of macrophages with rough and smooth Brucella melitensisA genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemiaMurine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradationExtensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.Functional interaction of nuclear domain 10 and its components with cytomegalovirus after infections: cross-species host cells versus native cells.Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.Nuclear domain 10 of the viral aspect.Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expressionNotch and Wnt signaling: mimicry and manipulation by gamma herpesviruses.Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp.Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription sitePromyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells.Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.Murine gammaherpesvirus 68 encodes a second PML-modifying protein.Nuclear remodelling during viral infections.Interplay between Herpesvirus Infection and Host Defense by PML Nuclear BodiesEpigenetic Alterations in Epstein-Barr Virus-Associated Diseases.Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis.Sp100 isoform-specific regulation of human adenovirus 5 gene expression.Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.H2B homology region of major immediate-early protein 1 is essential for murine cytomegalovirus to disrupt nuclear domain 10, but is not important for viral replication in cell culture.Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function.Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus.Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation.The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.
P2860
Q24298061-A4B5BBD3-EC32-4BDC-85A5-DBBBDB73592CQ24337028-554083A7-2A85-410D-8B53-DE66C598F89AQ24675055-C1FC8A7E-B8CB-49CF-935C-47F57977208DQ26865827-21E19971-50DF-4A42-80A6-35DA2FC5F04EQ27027918-6F49B43E-F9AC-44DB-94EA-9CB17F687ACDQ27315900-692B0711-BFCD-4F08-BB55-E9B1EE28839DQ28943555-CBD8EFE7-3734-46F3-8B97-7BB402FBBEE0Q33575096-C81E62A0-6AE4-4FBE-B44A-9D621517A394Q33749934-70F438E1-B873-4038-81EA-CC3F1B55212AQ33892537-3A8F345A-E9AB-45B2-B4BE-356086FBFAFAQ34334212-925B4DFF-5B35-4483-9FC7-43DD79D80F27Q34478739-B2BBEBA1-B7B0-4BE5-9F01-80FA2B417B17Q34977875-C439AA1C-45EB-4FE4-9219-DA1ED3131D2CQ35047491-3CB811AA-36B4-4266-AFA6-CEF43FE69C47Q35208258-5284C620-CA97-4814-A6FE-7C6092EF2B9FQ35539925-E5642831-C594-4286-AEA2-74EFBA2E5DB6Q35839875-9F99382C-E491-4DD7-91DA-80585CBDBA9DQ36306807-532F0F42-7F45-4CDD-A968-7778DBC7F48EQ36412174-DF47980F-59DF-4AE0-9784-DA88FC605082Q36480684-99671BE5-B059-49C5-AD35-E218B4F37DE3Q36498238-C89FA87F-5B52-49E5-ACDC-A5375D46AE71Q36803209-7C3FFBE4-AAEE-4252-B8FE-E174D263D821Q37254293-2233BD83-F62C-431E-9A10-9CE79E23935FQ37319836-A854136C-3993-409E-BCD6-E884C0036045Q37643766-40E2EE5A-641C-4DA6-AD2D-95E52039D3A0Q37866370-5B83BDA7-D6B5-4AE7-A242-69C712CBA1FFQ37945188-1AE25E2F-98DA-42C3-B96D-F7ADB7A39441Q38667123-163B6DDC-3305-4B24-9764-C49EFA280C19Q38751363-369931B7-ABC9-45F3-99C2-99220B915466Q38837130-C1749EF6-FBFA-4938-80E0-71F7F6A00096Q39016075-DBF620B0-741D-41C4-BE62-7B26BC2A5BA0Q39306073-D998D391-5017-4C71-8A10-B83213C20B36Q39532174-AA3FAE26-4490-4291-B20F-58BC0C270361Q39858749-96691539-4EF2-44BD-89E2-39A56E8757A6Q39977599-0016D12C-8776-45F7-B1E6-3A9C2667532DQ40030711-33F2B573-7E4A-4135-AD5E-9BCBDEF74FF3Q40134384-F54E16BD-16E2-4A3C-8552-4767B6EA4B50Q40274387-666990B2-4410-4487-8C0D-6D596F0BB00FQ40947307-BEBC5511-B41F-42D0-997B-3D8FB3987D2FQ41917994-1ED9FD58-C29D-4419-8D04-D2639A9A41CA
P2860
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@ast
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en-gb
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@nl
type
label
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@ast
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en-gb
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@nl
prefLabel
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@ast
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en-gb
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
@en
P2093
Ayako Nakajima
Jiang H Yu
Kenneth D Bloch
Paul D Ling
Rong Sheng Peng
Stephanie M Moses
Wei-Hong Yang
P2860
P304
P3181
P356
10.1038/SJ.EMBOJ.7600820
P407
P577
2005-10-19T00:00:00Z